APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 12 Mar 2018
At a glance
- Drugs Fenretinide (Primary)
- Indications Cystic fibrosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms APPLAUD
- Sponsors Laurent Pharmaceuticals
- 07 Mar 2018 Planned End Date changed from 1 Apr 2019 to 1 Oct 2019.
- 07 Mar 2018 Planned primary completion date changed from 1 Apr 2019 to 1 Oct 2019.
- 07 Mar 2018 Planned initiation date changed from 1 Dec 2017 to 1 Jun 2018.